Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alkermes plc - Ordinary Shares
(NQ:
ALKS
)
31.09
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 22, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
31.09
Bid (Size)
27.30 (1)
Ask (Size)
35.08 (2)
Prev. Close
31.09
Today's Range
31.09 - 31.09
52wk Range
25.16 - 36.45
Shares Outstanding
166,121,384
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz
October 22, 2025
Alkermes agrees to acquire Avadel for $2.1 billion, adding the successful Lumryz drug and accelerating entry into sleep medicine. Jazz litigation settled.
Via
Benzinga
Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition
October 22, 2025
DUBLIN, IRELAND – October 22, 2025 – Avadel Pharmaceuticals (NASDAQ: AVDL) shareholders are celebrating today as Alkermes plc (NASDAQ: ALKS) announced a definitive agreement to acquire the company for...
Via
MarketMinute
Topics
Intellectual Property
Performance
YTD
+8.1%
+8.1%
1 Month
+12.5%
+12.5%
3 Month
+14.3%
+14.3%
6 Month
+14.5%
+14.5%
1 Year
+10.6%
+10.6%
More News
Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated
October 22, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Earnings Scheduled For July 29, 2025
July 29, 2025
Via
Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
May 28, 2025
Via
Benzinga
Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives.
October 22, 2025
Via
Investor's Business Daily
Avadel Stock Rises After Acquisition Offer By Alkermes
October 22, 2025
Via
Stocktwits
9 Analysts Assess Alkermes: What You Need To Know
September 26, 2025
Via
Benzinga
This Ciena Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
September 26, 2025
Via
Benzinga
Deep Dive Into Alkermes Stock: Analyst Perspectives (7 Ratings)
September 03, 2025
Via
Benzinga
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
September 03, 2025
Via
Benzinga
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
September 03, 2025
Via
Benzinga
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
September 03, 2025
Via
Benzinga
ALKERMES PLC (NASDAQ:ALKS) Emerges as a Top Value Pick with Strong Fundamentals and Undervalued Metrics
August 05, 2025
Via
Chartmill
Alkermes PLC (NASDAQ:ALKS) Surges 7.8% Pre-Market After Q2 2025 Earnings Beat Revenue and EPS Estimates
July 29, 2025
Via
Chartmill
Topics
Earnings
Alkermes Q2 Sales Up 14 Percent
July 29, 2025
Via
The Motley Fool
Topics
Intellectual Property
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
July 21, 2025
Via
Investor's Business Daily
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
July 21, 2025
Via
Benzinga
Expert Outlook: Alkermes Through The Eyes Of 6 Analysts
July 15, 2025
Via
Benzinga
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit
July 07, 2025
Via
Stocktwits
ALKERMES PLC (NASDAQ:ALKS) – A Potential Undervalued Opportunity in Biopharma
July 04, 2025
Via
Chartmill
Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday
June 17, 2025
Via
Benzinga
This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
June 17, 2025
Via
Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
June 17, 2025
Via
Benzinga
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
May 28, 2025
Via
Benzinga
Frequently Asked Questions
Is Alkermes plc - Ordinary Shares publicly traded?
Yes, Alkermes plc - Ordinary Shares is publicly traded.
What exchange does Alkermes plc - Ordinary Shares trade on?
Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alkermes plc - Ordinary Shares?
The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market
What is the current price of Alkermes plc - Ordinary Shares?
The current price of Alkermes plc - Ordinary Shares is 31.09
When was Alkermes plc - Ordinary Shares last traded?
The last trade of Alkermes plc - Ordinary Shares was at 10/22/25 04:00 PM ET
What is the market capitalization of Alkermes plc - Ordinary Shares?
The market capitalization of Alkermes plc - Ordinary Shares is 5.16B
How many shares of Alkermes plc - Ordinary Shares are outstanding?
Alkermes plc - Ordinary Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.